Allogene Therapeutics ALLO Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Allogene Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Allogene Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Allogene Therapeutics's common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Allogene Therapeutics's common stock shares issued?
- Allogene Therapeutics (ALLO) reported common stock shares issued of 244.8M in Q1 2026.
- How has Allogene Therapeutics's common stock shares issued changed year-over-year?
- Allogene Therapeutics's common stock shares issued increased by 12.0% year-over-year, from 218.6M to 244.8M.
- What is the long-term trend for Allogene Therapeutics's common stock shares issued?
- Over 5 years (2020 to 2025), Allogene Therapeutics's common stock shares issued has grown at a 10.3% compound annual growth rate (CAGR), from 140.5M to 229.4M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.